Legal & General Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,298
Closed -$5.68K 3458
2026
Q1
$5.68K Sell
17,298
-2,983
-15% -$4.69K ﹤0.01% 3269
2025
Q4
$62.9K Sell
20,281
-610
-3% -$1.74K ﹤0.01% 2686
2025
Q3
$54.8K Sell
20,891
-268
-1% -$591 ﹤0.01% 2713
2025
Q2
$26K Buy
+21,159
New +$23.1K ﹤0.01% 2897
2023
Q2
Sell
-7,451
Closed -$9.39K 3448
2023
Q1
$9.39K Sell
7,451
-13,115
-64% -$25.1K ﹤0.01% 3216
2022
Q4
$44.6K Sell
20,566
-410
-2% -$3.38K ﹤0.01% 2966
2022
Q3
$251K Buy
20,976
+3,075
+17% +$38.2K ﹤0.01% 2541
2022
Q2
$150K Sell
17,901
-126
-0.7% -$976 ﹤0.01% 2738
2022
Q1
$156K Buy
18,027
+474
+3% +$4.57K ﹤0.01% 2751
2021
Q4
$199K Sell
17,553
-285
-2% -$3.38K ﹤0.01% 2727
2021
Q3
$225K Buy
17,838
+9,997
+127% +$92K ﹤0.01% 2646
2021
Q2
$63K Sell
7,841
-624
-7% -$5.41K ﹤0.01% 2882
2021
Q1
$79K Sell
8,465
-212
-2% -$2.14K ﹤0.01% 2681
2020
Q4
$84K Hold
8,677
﹤0.01% 2633
2020
Q3
$107K Sell
8,677
-1,444
-14% -$19.1K ﹤0.01% 2467
2020
Q2
$132K Buy
10,121
+2,994
+42% +$37.7K ﹤0.01% 2455
2020
Q1
$72K Sell
7,127
-1,952
-22% -$25.5K ﹤0.01% 2497
2019
Q4
$141K Buy
9,079
+956
+12% +$19.3K ﹤0.01% 2489
2019
Q3
$137K Buy
8,123
+3,799
+88% +$75.5K ﹤0.01% 2437
2019
Q2
$96K Buy
4,324
+2,577
+148% +$49.3K ﹤0.01% 2547
2019
Q1
$38K Buy
+1,747
New +$36.4K ﹤0.01% 2815

Other funds holding GOSS

Legal & General Group's GOSS Position: Q2 2026 in Review

Legal & General Group sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 17,298 shares — an estimated $5.68K sold.

Legal & General Group first reported a position in GOSS in Q1 2019 and held it in 21 quarters. The position peaked at $251K in Q3 2022. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Legal & General Group reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Legal & General Group sold 17,298 Gossamer Bio shares in Q2 2026, an estimated $5.68K.
  • Legal & General Group first reported a position in Gossamer Bio in Q1 2019 and held it in 21 quarters.
  • Legal & General Group's Gossamer Bio position peaked at $251K in Q3 2022.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.